- Home
- RLAY vs UFCS Comparison
RLAY vs UFCS Comparison
Compare RLAY & UFCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- UFCS
- Stock Information
- Founded
- RLAY 2015
- UFCS 1946
- Country
- RLAY United States
- UFCS United States
- Employees
- RLAY N/A
- UFCS N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- UFCS Property-Casualty Insurers
- Sector
- RLAY Health Care
- UFCS Finance
- Exchange
- RLAY Nasdaq
- UFCS Nasdaq
- Market Cap
- RLAY 723.1M
- UFCS 642.7M
- IPO Year
- RLAY 2020
- UFCS N/A
- Fundamental
- Price
- RLAY $4.94
- UFCS $25.92
- Analyst Decision
- RLAY Strong Buy
- UFCS Hold
- Analyst Count
- RLAY 10
- UFCS 1
- Target Price
- RLAY $20.11
- UFCS $26.00
- AVG Volume (30 Days)
- RLAY 2.9M
- UFCS 151.3K
- Earning Date
- RLAY 02-20-2025
- UFCS 02-11-2025
- Dividend Yield
- RLAY N/A
- UFCS 2.42%
- EPS Growth
- RLAY N/A
- UFCS N/A
- EPS
- RLAY N/A
- UFCS 1.94
- Revenue
- RLAY $10,006,000.00
- UFCS $1,207,451,000.00
- Revenue This Year
- RLAY N/A
- UFCS N/A
- Revenue Next Year
- RLAY N/A
- UFCS $11.31
- P/E Ratio
- RLAY N/A
- UFCS $13.59
- Revenue Growth
- RLAY N/A
- UFCS 10.95
- 52 Week Low
- RLAY $3.50
- UFCS $18.04
- 52 Week High
- RLAY $11.16
- UFCS $31.70
- Technical
- Relative Strength Index (RSI)
- RLAY 53.29
- UFCS 37.21
- Support Level
- RLAY $3.50
- UFCS $25.20
- Resistance Level
- RLAY $5.99
- UFCS $27.43
- Average True Range (ATR)
- RLAY 0.54
- UFCS 0.75
- MACD
- RLAY 0.06
- UFCS -0.15
- Stochastic Oscillator
- RLAY 49.40
- UFCS 24.67
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About UFCS United Fire Group Inc.
United Fire Group Inc is engaged in the business of writing property and casualty insurance and selling annuities through a network of independent agencies. The company's only operating segment is property and casualty insurance, which includes commercial lines insurance, personal lines insurance, and assumed reinsurance. The primary source of revenue is premium and investment income.